HIV Stories
The sudden withdrawal of US funding earlier this year has intensified financial pressure on households, disrupting treatment for chronic conditions su...
Under the deal, the United States will provide US$1.6 billion (Sh208 billion) over five years, while Kenya will contribute approximately US$850 millio...
Kenya’s overall HIV prevalence was reported at three per cent, with women experiencing a higher rate at just over four per cent compared with two per...
New data from African trials and global studies show long-acting HIV injections can match daily pills for viral suppression and prevention, with fewer...
Deputy Governor Josphat Chirema Kombo urged residents, particularly the youth, to make HIV testing a routine part of their health care, saying early k...
Turkana County leaders used World AIDS Day in Lodwar to warn of rising HIV infections and deaths, unveil new highway health outreach, and urge shared...
The Kenyan Ministry of Health emphasises the importance of youth leadership in the fight against AIDS, urging young people to influence health policie...
German researchers have discovered an antibody that is extremely effective against HIV, at least in the laboratory. Could it be a new weapon against A...
The Tribunal had earlier found that KDF officers subjected him to HIV testing without consent, failed to provide mandatory pre- and post-test counsell...
Gilead is seeking regulatory approval to distribute lenacapavir in additional African countries, including Kenya, Rwanda, Tanzania and Botswana.
Early detection could prevent thousands of cervical cancer deaths in Kenya, yet most women remain unscreened and at risk due to persistent gaps in hea...
Scientists uncover a Tanzanian woman’s antibody that neutralizes nearly every HIV strain, offering new hope for prevention and treatment.
Lenacapavir is administered once every six months and offers protection against HIV infection for the same duration.
In Kenya, cardiovascular disease is an increasingly significant cause of illness and death. Recent data show that about 25 per cent of hospital admiss...
Lenacapavir is administered as a six-monthly injection, starting with a subcutaneous initiation dose, supported by tablets on days one and two.
With opposition figures barred and regional instability looming, Ivory Coast’s 2025 presidential vote tests the resilience of its democracy and the su...
Ehivet, who will be contesting under a Movement of Skilled Generations party ticket, faces four other candidates, including current president Alassane...
In 2024, 20,105 adults were newly infected with HIV - a sharp rise from 3,353 cases recorded in 2023. Infections among children also surged from 606 t...
When donor funding for vulnerable groups was first withdrawn, there was hope that some form of cushioning would ease the transition. But months later,...
Several southern African countries started their national circumcision programmes to prevent HIV in 2010. As of 2023, 37 million voluntary medical mal...
Patients and experts alike warn that the once-celebrated progress in HIV management is now unravelling, leaving vulnerable groups to fend for themselv...
The dialogue ended with a unanimous call for a coordinated, multi-sectoral approach to tackle the root causes of HIV, adolescent pregnancies, and gend...
KPDA cautioned that the shortages could drive medicine prices up by as much as 50 per cent, worsening the strain on households already facing high hea...
According to the report, 20,105 adults were newly infected with HIV last year, a sharp rise from the 3,353 cases recorded in 2023.
Cervical cancer remains a serious public health challenge in Kenya, killing at least nine women daily. The emotional and financial burden of treatment...
In total, Kenya now has an estimated 1,326,419 people living with HIV, comprising 867,571 females and 458,848 males.
The signing underscores a shared commitment by UNAIDS and Africa CDC to achieving the Sustainable Development Goals and building a healthier, more res...
The cheaper version is expected to reach 120 low- and middle-income countries from 2027, pending regulatory approval.
This achievement is underpinned by widespread testing, expanded antiretroviral treatment, and comprehensive prevention efforts.
There’s also stigma. Older adults grew up during a time when HIV was associated with silence and shame. Many feel deep embarrassment or fear about get...
